Preclinical Efficacy of CHK-336: A First in Class, Liver-Targeted, Small Molecule Inhibitor of Lactate Dehydrogenase for the Treatment of Primary Hyperoxalurias: FR-PO334
Gespeichert in:
| Veröffentlicht in: | Journal of the American Society of Nephrology 2022-11, Vol.33 (11S), p.415-415 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 415 |
|---|---|
| container_issue | 11S |
| container_start_page | 415 |
| container_title | Journal of the American Society of Nephrology |
| container_volume | 33 |
| creator | Cox, Jennifer H. Boily, Marc-Olivier Caron, Alex Chong, Oliver Ding, Jim Gaudreault, Samuel Gomez, Robert Knight, John Lester, Jeff Li, Xingsheng Lowther, W. T. Oballa, Renata Powell, David A. Sheng, Tao Surendradoss, Jayakumar Tong, Vincent Wu, Joyce King, Andrew J. |
| description | |
| doi_str_mv | 10.1681/ASN.20223311S1415d |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1681_ASN_20223311S1415d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1681_ASN_20223311S1415d</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1681_ASN_20223311S1415d3</originalsourceid><addsrcrecordid>eNqdj01OwzAUhL0AifJzAVbvAE2x4zZB7KrQKoiCKiX7yDjPjZGTVM8uIrfhqCSCDVtWs5j5RvoYuxV8IZJ7cbcuXhcxj2MphSjEUqzqMzYTfJlESZLKC3bp_TvnYhWn6Yx97Qm1s53VysHGmDH1AL2BLH-OpEweYA1bSz6A7SBzyvs57OwHUlQqOmDAeg5Fq5yDl96hPjmEp66xbzb0NN3slA4qIDxiM9TUH7BTHsGMZWgQSkIVWuzCNN2TbRUNkA9HpP5TuRNZ5a_ZuVHO481vXrF4uymzPNLUe09oquMPVwleTf7V6F_99Zf_gr4BXDJnKg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Preclinical Efficacy of CHK-336: A First in Class, Liver-Targeted, Small Molecule Inhibitor of Lactate Dehydrogenase for the Treatment of Primary Hyperoxalurias: FR-PO334</title><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Cox, Jennifer H. ; Boily, Marc-Olivier ; Caron, Alex ; Chong, Oliver ; Ding, Jim ; Gaudreault, Samuel ; Gomez, Robert ; Knight, John ; Lester, Jeff ; Li, Xingsheng ; Lowther, W. T. ; Oballa, Renata ; Powell, David A. ; Sheng, Tao ; Surendradoss, Jayakumar ; Tong, Vincent ; Wu, Joyce ; King, Andrew J.</creator><creatorcontrib>Cox, Jennifer H. ; Boily, Marc-Olivier ; Caron, Alex ; Chong, Oliver ; Ding, Jim ; Gaudreault, Samuel ; Gomez, Robert ; Knight, John ; Lester, Jeff ; Li, Xingsheng ; Lowther, W. T. ; Oballa, Renata ; Powell, David A. ; Sheng, Tao ; Surendradoss, Jayakumar ; Tong, Vincent ; Wu, Joyce ; King, Andrew J.</creatorcontrib><identifier>ISSN: 1046-6673</identifier><identifier>DOI: 10.1681/ASN.20223311S1415d</identifier><language>eng</language><ispartof>Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.415-415</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Cox, Jennifer H.</creatorcontrib><creatorcontrib>Boily, Marc-Olivier</creatorcontrib><creatorcontrib>Caron, Alex</creatorcontrib><creatorcontrib>Chong, Oliver</creatorcontrib><creatorcontrib>Ding, Jim</creatorcontrib><creatorcontrib>Gaudreault, Samuel</creatorcontrib><creatorcontrib>Gomez, Robert</creatorcontrib><creatorcontrib>Knight, John</creatorcontrib><creatorcontrib>Lester, Jeff</creatorcontrib><creatorcontrib>Li, Xingsheng</creatorcontrib><creatorcontrib>Lowther, W. T.</creatorcontrib><creatorcontrib>Oballa, Renata</creatorcontrib><creatorcontrib>Powell, David A.</creatorcontrib><creatorcontrib>Sheng, Tao</creatorcontrib><creatorcontrib>Surendradoss, Jayakumar</creatorcontrib><creatorcontrib>Tong, Vincent</creatorcontrib><creatorcontrib>Wu, Joyce</creatorcontrib><creatorcontrib>King, Andrew J.</creatorcontrib><title>Preclinical Efficacy of CHK-336: A First in Class, Liver-Targeted, Small Molecule Inhibitor of Lactate Dehydrogenase for the Treatment of Primary Hyperoxalurias: FR-PO334</title><title>Journal of the American Society of Nephrology</title><issn>1046-6673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqdj01OwzAUhL0AifJzAVbvAE2x4zZB7KrQKoiCKiX7yDjPjZGTVM8uIrfhqCSCDVtWs5j5RvoYuxV8IZJ7cbcuXhcxj2MphSjEUqzqMzYTfJlESZLKC3bp_TvnYhWn6Yx97Qm1s53VysHGmDH1AL2BLH-OpEweYA1bSz6A7SBzyvs57OwHUlQqOmDAeg5Fq5yDl96hPjmEp66xbzb0NN3slA4qIDxiM9TUH7BTHsGMZWgQSkIVWuzCNN2TbRUNkA9HpP5TuRNZ5a_ZuVHO481vXrF4uymzPNLUe09oquMPVwleTf7V6F_99Zf_gr4BXDJnKg</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Cox, Jennifer H.</creator><creator>Boily, Marc-Olivier</creator><creator>Caron, Alex</creator><creator>Chong, Oliver</creator><creator>Ding, Jim</creator><creator>Gaudreault, Samuel</creator><creator>Gomez, Robert</creator><creator>Knight, John</creator><creator>Lester, Jeff</creator><creator>Li, Xingsheng</creator><creator>Lowther, W. T.</creator><creator>Oballa, Renata</creator><creator>Powell, David A.</creator><creator>Sheng, Tao</creator><creator>Surendradoss, Jayakumar</creator><creator>Tong, Vincent</creator><creator>Wu, Joyce</creator><creator>King, Andrew J.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202211</creationdate><title>Preclinical Efficacy of CHK-336: A First in Class, Liver-Targeted, Small Molecule Inhibitor of Lactate Dehydrogenase for the Treatment of Primary Hyperoxalurias</title><author>Cox, Jennifer H. ; Boily, Marc-Olivier ; Caron, Alex ; Chong, Oliver ; Ding, Jim ; Gaudreault, Samuel ; Gomez, Robert ; Knight, John ; Lester, Jeff ; Li, Xingsheng ; Lowther, W. T. ; Oballa, Renata ; Powell, David A. ; Sheng, Tao ; Surendradoss, Jayakumar ; Tong, Vincent ; Wu, Joyce ; King, Andrew J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1681_ASN_20223311S1415d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cox, Jennifer H.</creatorcontrib><creatorcontrib>Boily, Marc-Olivier</creatorcontrib><creatorcontrib>Caron, Alex</creatorcontrib><creatorcontrib>Chong, Oliver</creatorcontrib><creatorcontrib>Ding, Jim</creatorcontrib><creatorcontrib>Gaudreault, Samuel</creatorcontrib><creatorcontrib>Gomez, Robert</creatorcontrib><creatorcontrib>Knight, John</creatorcontrib><creatorcontrib>Lester, Jeff</creatorcontrib><creatorcontrib>Li, Xingsheng</creatorcontrib><creatorcontrib>Lowther, W. T.</creatorcontrib><creatorcontrib>Oballa, Renata</creatorcontrib><creatorcontrib>Powell, David A.</creatorcontrib><creatorcontrib>Sheng, Tao</creatorcontrib><creatorcontrib>Surendradoss, Jayakumar</creatorcontrib><creatorcontrib>Tong, Vincent</creatorcontrib><creatorcontrib>Wu, Joyce</creatorcontrib><creatorcontrib>King, Andrew J.</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cox, Jennifer H.</au><au>Boily, Marc-Olivier</au><au>Caron, Alex</au><au>Chong, Oliver</au><au>Ding, Jim</au><au>Gaudreault, Samuel</au><au>Gomez, Robert</au><au>Knight, John</au><au>Lester, Jeff</au><au>Li, Xingsheng</au><au>Lowther, W. T.</au><au>Oballa, Renata</au><au>Powell, David A.</au><au>Sheng, Tao</au><au>Surendradoss, Jayakumar</au><au>Tong, Vincent</au><au>Wu, Joyce</au><au>King, Andrew J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preclinical Efficacy of CHK-336: A First in Class, Liver-Targeted, Small Molecule Inhibitor of Lactate Dehydrogenase for the Treatment of Primary Hyperoxalurias: FR-PO334</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><date>2022-11</date><risdate>2022</risdate><volume>33</volume><issue>11S</issue><spage>415</spage><epage>415</epage><pages>415-415</pages><issn>1046-6673</issn><doi>10.1681/ASN.20223311S1415d</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1046-6673 |
| ispartof | Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.415-415 |
| issn | 1046-6673 |
| language | eng |
| recordid | cdi_crossref_primary_10_1681_ASN_20223311S1415d |
| source | PubMed Central; EZB Electronic Journals Library |
| title | Preclinical Efficacy of CHK-336: A First in Class, Liver-Targeted, Small Molecule Inhibitor of Lactate Dehydrogenase for the Treatment of Primary Hyperoxalurias: FR-PO334 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T20%3A48%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preclinical%20Efficacy%20of%20CHK-336:%20A%20First%20in%20Class,%20Liver-Targeted,%20Small%20Molecule%20Inhibitor%20of%20Lactate%20Dehydrogenase%20for%20the%20Treatment%20of%20Primary%20Hyperoxalurias:%20FR-PO334&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Cox,%20Jennifer%20H.&rft.date=2022-11&rft.volume=33&rft.issue=11S&rft.spage=415&rft.epage=415&rft.pages=415-415&rft.issn=1046-6673&rft_id=info:doi/10.1681/ASN.20223311S1415d&rft_dat=%3Ccrossref%3E10_1681_ASN_20223311S1415d%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |